Ipea's anti-malarial product pre-qualified by WHO

摘要

Ipca Laboratories has received approval for its anti-malarial finished product formulation,artesunate tablets 50 mg under World Health Organization's (WHO's) Pre-qualification Programme.The product is now listed in the WHO Pre-qualification product list,dated 30 August,2007.The product is an artemisinin based formulation which is recommended by WHO to be used in combination with other antimalarials.